Skip to main content
SpringerLink
Log in

Epilepsien: Medikamentöse Therapie

  • Living reference work entry
  • First Online:
Klinische Neurologie

Part of the book series: Springer Reference Medizin ((SRM))

  • 332 Accesses

Zusammenfassung

Nach Auftreten zweier epileptischer Anfälle oder eines Anfalls bei Vorliegen bildgebender oder elektroenzephalografischer Risikofaktoren für weitere Anfälle besteht die Indikation zur medikamentösen Anfallsprophylaxe. Die Pharmakotherapie von Epilepsien erzielt bei zwei von drei Patienten eine anhaltende Anfallskontrolle. Moderne Antiepileptika ermöglichen auch in Kombination eine gut verträgliche und interaktionsarme Behandlung ohne negative Langzeitbehandlungsfolgen. Bei sich abzeichnender Pharmakoresistenz ist eine frühe Vorstellung an Epilepsiezentren zur Diagnosesicherung und/oder Evaluation nichtmedikamentöser Behandlungsoptionen erforderlich.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Literatur

  • Arif H, Buchsbaum R, Weintraub D, Koyfman S, Salas-Humara C, Bazil CW, Resor SR Jr, Hirsch LJ (2007) Comparison and predictors of rash associated with 15 antiepileptic drugs. Neurology 68:1701–1709

    Article  CAS  Google Scholar 

  • Beghi E, Gatti G, Tonini C et al (2003) Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicenter, randomized, pragmatic, controlled trial. Epilepsy Res 57:1–13

    Article  CAS  Google Scholar 

  • Berg AT, Shinnar S (1994) Relapse following discontinuation of antiepileptic drugs: a a meta-analysis. Neurology 44:601–608

    Article  CAS  Google Scholar 

  • Birbeck GL, Hays RD, Cui X, Vickrey BG (2002) Seizure reduction and quality of life improvements in people with epilepsy. Epilepsia 43(5):535–8

    Google Scholar 

  • Brodie MJ, Yuen AW (1997) Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group. Epilepsy Res 26:423–432

    Article  CAS  Google Scholar 

  • Canevini MP, Mai R, DiMarco C et al (1992) Juvenile myoclonic epilepsy of Janz: clinical observations in 60 patients. Seizure 1:291–298

    Article  CAS  Google Scholar 

  • Chadwick D (1991) Randomized trial on antiepileptic drug withdrawal in patients in remission. Lancet 337:1175–1181

    Google Scholar 

  • Delgado-Escueta AV, Enrile-Bacsal F (1984) Juvenile myoclonic epilepsy of Janz. Neurology 34:285–294

    Article  CAS  Google Scholar 

  • Döring J, Syrbe S (2019) Neue Entwicklungen in der genetischen Grundlage kortikaler Malformationen. Z Epileptol 32:303–310. https://doi.org/10.1007/s10309-019-0266-6

  • Grosso S, Galimberti D, Vezzani P et al (2005) Course and outcome of childhood epilepsy: evolution and prognostic factors. Epilepsia 46:1796–1801

    Article  Google Scholar 

  • Hughes DM, Bonnett LJ, Czanner G, Komárek A, Marson AG, García-Fiñana M (2018) Identification of patients who will not achieve seizure remission within 5 years on AEDs. Neurology 91:e2035–e2044

    Article  Google Scholar 

  • Kwan P, Brodie MJ (2000) Early identification of refractory epilepsy. N Engl J Med 342:314–319

    Article  CAS  Google Scholar 

  • Kwan P, Arzomanoglou A, Bert AT, Brodie M, Hauser A, Mathern G et al (2010) Definition of drug-resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia 51:1069–1077

    Article  CAS  Google Scholar 

  • Kwan P, Schachter SC, Brodie MJ (2011) Drug-resistant epilepsy. N Engl J Med 365:919–926

    Article  CAS  Google Scholar 

  • Lang JD, Kostev K, Onugoren MD, Gollwitzer S, Graf W, Müller T, Olmes DG, Hamer HM (2018) Switching the manufacturer of antiepileptic drugs is associated with higher risk of seizures: a nationwide study of prescription data in Germany. Ann Neurol 84:918–925

    Article  CAS  Google Scholar 

  • Laville F, Montana M, Roux N, Rathelot P, Giorgi R, Vanelle P (2018) Factors limiting adherence to antiepileptic treatment: a French online patient survey. J Clin Pharm Ther 43:73–79

    Article  Google Scholar 

  • Lee BI, No SK, Yi SD et al (2018) Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy. Seizure 55:17–24

    Article  Google Scholar 

  • Lee BI, Park KM, Kim SE, Heo K (2019) Clinical opinion: earlier employment of polytherapy in sequential pharmacotherapy of epilepsy. Epilepsy Res 156:106165

    Article  Google Scholar 

  • Lossius MI, Hessen E, Mowinckel P et al (2008) Consequences of antiepileptic drug withdrawal : a randomized, double-blind study (Akershus Study). Epilepsia 49:455–463

    Article  Google Scholar 

  • Marson AG, Al-Kharusi AM, Alwaidh M et al (2007a) The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 369:1000–1015

    Article  CAS  Google Scholar 

  • Marson AG, Al-Kharusi AM, Alwaidh M et al (2007b) The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 369:1016–1026

    Article  CAS  Google Scholar 

  • Meador KJ, Baker GA, Browning N et al (2014) Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) Study Group. JAMA Pediatr 168:729–736

    Article  Google Scholar 

  • Mielke H, Meissner S, Wagner K, Joos A, Schulze-Bonhage A (2020) Which seizure elements do patients memorize? A comparison of history and seizure documentation. Epilepsia, im Druck

    Google Scholar 

  • Ryther RC, Wong M (2012) Mammalian target of rapamycin (mTOR) inhibition: potential for antiseizure, antiepileptigenic, and epileptostatic therapy. Curr Neurol Sci Rep 12:410–218

    Google Scholar 

  • Sake JK, Hebert D, Isojärvi J, Doty P, De Backer M, Davies K, Eggert-Formella A, Zackheim J (2010) A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs. CNS Drugs 24:1055–1068

    Article  CAS  Google Scholar 

  • Scheffer IE, Berkovic S, Capovilla G et al (2017 Apr) ILAE classification of the epilepsies: Position paper of the ILAE commission for classification and terminology. Epilepsia 58(4):512–521. https://doi.org/10.1111/epi.13709

    Article  PubMed  PubMed Central  Google Scholar 

  • Schiller Y, Najjar Y (2008) Quantifying the response to antiepileptic drugs: effect of past treatment history. Neurology 70:54–65

    Google Scholar 

  • Schmeiser B, Steinhoff BJ, Schulze-Bonhage A (2018) Does early postoperative drug regimen impact seizure control in patients undergoing temporal lobe resections? J Neurol 265:500–509

    Article  Google Scholar 

  • Schulze-Bonhage A (2017) A 2017 review of pharmacotherapy for treating focal epilepsy: where are we now and how will treatment develop? Expert Opin Pharmacother 18:1845–1853

    Article  CAS  Google Scholar 

  • Schulze-Bonhage A (2019a) Orphan drugs in der Epileptologie. Z Epileptologie

    Google Scholar 

  • Schulze-Bonhage A (2019b) Epileptogenesis in symptomatic Epilepsy. In: Shorvon S, Guerrini R, Schachter S, Trinka E (Hrsg) The Causes of Epilepsy, 2. Aufl. Cambridge University Press, Cambridge, S 35–45

    Google Scholar 

  • Schulze-Bonhage A, Hintz M (2015) Perampanel in the management of partial-onset seizures: a review of safety, efficacy, and patient acceptability. Patient Prefer Adherence 9:1143–1151

    Article  Google Scholar 

  • Schulze-Bonhage A, Böttcher S, Glasstetter M, Epitashvili N, Bruno E, Richardson M, Laerhoven KV (2019) Dümpelmann M. Mobiles Anfallsmonitoring bei Epilepsiepatienten. Nervenarzt. https://doi.org/10.1007/s00115-019-00822-x. Z Epileptol 32:277–285. https://doi.org/10.1007/s10309-019-0274-6

  • Semah F, Picot MC, Adam C et al (1998) Ist he underlying cause of epilepsy a major prognostic factor for recurrence? Neurology 51:1256–1262

    Article  CAS  Google Scholar 

  • Specchio LM, Tramacere I, La Neve A, Beghi E (2002) Discontinuing antiepileptic drugs in patients who are seizure-free on monotherapy. J Neurol Neurosurg Psychiatry 72:22–22

    Article  CAS  Google Scholar 

  • Spooner CG, Berkovic SF, Mitchell LA, Wrennall JA, Harvey AS (2006) New-onset temporal lobe epilepsy in children: lesion on MRI predicts poor seizure outcome. Neurology 67:2147–2153

    Article  CAS  Google Scholar 

  • Tomson T, Battino D, Bonizzoni E et al (2016) Withdrawal of valproic acid treatment during pregnancy and seizure outcome: observations from EURAP. Epilepsia 57:e173–e177

    Article  CAS  Google Scholar 

  • Tomson T, Battino D, Bonizzoni E et al (2018) Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol 17:530–538

    Article  CAS  Google Scholar 

  • Tomson T, Battino D, Bonizzoni E et al (2019) Declining malformation rates with changed antiepileptic drug prescribing: an observational study. Neurology 93:e831–e840

    Article  Google Scholar 

  • Vajda FJE, O’Brien TJ, Graham JE et al (2019) Valproate-associated foetal malformations-rates of occurrence, risks in attempted avoidance. Acta Neurol Scand 139:42–48

    Article  CAS  Google Scholar 

  • Williams J, Lawthom C, Dunstan FD, Dawson TP, Kerr MP, Wilson JF (2006) Smith PE Variability of antiepileptic medication taking behaviour in sudden unexplained death in epilepsy: hair analysis at autopsy. J Neurol Neurosurg Psychiatry 77:481–484

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Epilepsiezentrum, Universitätsklinikum Freiburg, Freiburg, Deutschland

    Andreas Schulze-Bonhage

Authors
  1. Andreas Schulze-Bonhage
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas Schulze-Bonhage .

Editor information

Editors and Affiliations

  1. Essen, Germany

    Peter Berlit

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Schulze-Bonhage, A. (2020). Epilepsien: Medikamentöse Therapie. In: Berlit, P. (eds) Klinische Neurologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44768-0_119-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-44768-0_119-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-44768-0

  • Online ISBN: 978-3-662-44768-0

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics

Search

Navigation